Dylan Lauri Steen , MD
Adjunct Associate Professor
Director of Clinical Trials and Population Health Research, UC Heart, Lung and Vascular Institute
Internal Medicine
Medical Sciences Building Room 6065
231 Albert Sabin Way, MLC 0542
Cincinnati, Ohio 45267
Phone 513-558-1067
Email dylan.steen@uc.edu
Education
Medical Degree: Robert Wood Johnson Medical School 2005
Masters of Sciences: Harvard School of Public Health 2014 (Epidemiology)
Internal Medicine Residency: Jackson Memorial Hospital 2008
Cardiovascular Disease Fellowship: Jackson Memorial Hospital 2011
Clinical Research Fellowship: T.I.M.I. Study Group, Harvard University 2014
Undergraduate Degree: Cook College, Rutgers University New Brunswick, NJ, 2000
Certifications
American Board of Internal Medicine (Cardiovascular Disease) (Certification Date: 11-02-2012 ) - (Recertification Date: to 12-29-2022 )
Clinical Interests
Cardiology
Cardiovascular Disease
Obesity
Shortness of Breath
Specialities
Cardiovascular Disease
Echocardiography
Internal Medicine
Nuclear Cardiology
Research Support
Grant: #URS Strategic Collaborative Grants AY2017-2018 Investigators:Steen, Dylan 05-01-2018 -10-31-2019 UC's Research Support SUPERmaket and Web-based Inerventions targeting Nutrition for CVD Risk Reduction (SUPERWIN) Role:PI $97,336.00 Active Level:Internal UC
Grant: #R40217 Investigators:Steen, Dylan 07-01-2020 -12-31-2021 UC's Collaborative Research Advancement Grant Program - Track 1: Pilot Teams SUPERmarket and Web-based Intervention targeting Nutrition (SuperWIN) for CVD Risk Reduction Role:PI $25,000.00 Active Level:Internal UC
Grant: #CKJX839B12302 10-04-2021 -10-04-2024 Novartis AG A randomized, double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease... Role:PI 319472.19 Hold Level:Industry
Grant: #CKJX839B12302 10-04-2021 -10-04-2024 Novartis AG A randomized, double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease... Role:PI 319472.19 Hold Level:Industry
Grant: #AROAPOC3-3003 SHASTA 10-28-2024 -10-27-2027 IQVIA Clinical Trial Payments DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHASTA-3 STUDY) Role:PI 312823.54 Hold Level:Industry
Grant: #AROAPOC3-3003 SHASTA 10-28-2024 -10-27-2027 IQVIA Clinical Trial Payments DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHASTA-3 STUDY) Role:PI 312823.54 Hold Level:Industry
Publications
Peer Reviewed Publications
O'Donoghue ML, Braunwald E, White HD, Steen DL, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP. (2014. ) Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.JAMA, , 312 (10 ) ,1006-15 More Information
Steen, Dylan L; Bhatt, Deepak L (2014. ) Statin potency associated with incident diabetes in a real-world evaluation.Evidence-based medicine, , 19 (2 ) ,68 More Information
Steen, Dylan L; O'Donoghue, Michelle L (2013. ) Lp-PLA2 Inhibitors for the Reduction of Cardiovascular Events.Cardiology and therapy, , 2 (2 ) ,125-34 More Information
Steen, Dylan L; Cannon, Christopher P; Lele, Suhas S; Rajapurkar, Mohan M; Mukhopadhyay, Banibrata; Scirica, Benjamin M; Murphy, Sabina A; Morrow, David A (2013. ) Prognostic evaluation of catalytic iron in patients with acute coronary syndromes.Clinical cardiology, , 36 (3 ) ,139-45 More Information
Hebert, Kathy; Quevedo, Henry C; Tamariz, Leonardo; Dias, Andre; Steen, Dylan L; Colombo, Rosario A; Franco, Emiliana; Neistein, Sholom; Arcement, Lee M (2012. ) Prevalence of conduction abnormalities in a systolic heart failure population by race, ethnicity, and gender.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, , 17 (2 ) ,113-22 More Information
Steen, Dylan L; Cannon, Christopher P (2012. ) Atherosclerosis. Effects of evacetrapib administered as monotherapy or in combination with statins. Reviews in cardiovascular medicine, , 13 (1 ) ,e48-51
Hebert, Kathy; Lopez, Barbara; Dias, Andre; Steen, Dylan L; Colombo, Rosario A; Franco, Emiliana; Neistein, Sholom; Arcement, Lee M Prevalence of electrocardiographic abnormalities in a systolic heart failure disease management population by race, ethnicity, and sex.Congestive heart failure (Greenwich, Conn.), , 16 (1 ) ,21-6 More Information
Steen, D.L. (2014. ) The Revised ACC/AHA/HRS Guidelines for the Management of Patients With Atrial Fibrillation. http://anticoagulation.cardiosource.org. September 25, 2014. Accessed Oct 2, 2014. http://anticoagulation.cardiosource.org/Hot-Topics/2014/09/Revised-Guidelines-for-the-Management-of-Patients-With-Atrial-Fibrillation.aspx .
Steen D.L,, O’Donoghue M.L. (2013. ) Inhibitors for the Reduction of Cardiovascular Events. Cardiology and Therapy. Cardiology and Therapy, , 2 (2 ) ,125
Steen D.L. (2013. ) A Middle-Aged Man With AFib and Mechanical Heart Valve. .http://anticoagulation.cardiosource.org, ,
Steen DL, Khera AV, Cannon CP (2013. ) Anacetrapib: Potential for the prevention and treatment of coronary heart disease. Research Reports in Clinical Cardiology, , 4 ,39
Steen DL, Wiviott SD, Cannon CP (2012. ) HDL and CETP Inhibition .http://www.cardiosource.org/Science-And-Quality/Expert-Opinions-and-Cases/Hot-Topics/2012/02/HDL-and-CETP-Inhibition.aspx, ,
Hebert K, Dias A, Franco E, Tamariz L, Steen D, Arcement LM (2011. ) Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program. .Congestive Heart Failure, , 17 (6 ) ,309
Contact Information
Academic - Internal Medicine
Medical Sciences Building Room 6065
Cincinnati
Ohio, 45267
Phone: 513-558-1067
dylan.steen@uc.edu